These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3773366)

  • 1. [Blood lactate threshold in patients with bronchogenic carcinoma].
    Miyoshi S; Monden Y; Nakahara K; Ohno K; Fujii Y; Hashimoto J; Kitagawa Y; Kido T; Maeda H; Ikeda M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1986 Jun; 24(6):618-24. PubMed ID: 3773366
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum hCG in bronchogenic carcinoma.
    Behera D; Dash S; Malik SK; Dash RJ
    Indian J Chest Dis Allied Sci; 1984; 26(4):238-41. PubMed ID: 6545265
    [No Abstract]   [Full Text] [Related]  

  • 3. Tissue polypeptide antigen in bronchogenic carcinoma.
    Zatloukal P; Glagolicová A; Linhart M; Sebes A; Hencl P; Mĕricka O
    Neoplasma; 1993; 40(5):301-3. PubMed ID: 8272159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta-2-microglobulin in bronchogenic carcinoma].
    Zatloukal P; Dudková V; Mĕricka O
    Sb Lek; 1990; 92(11-12):366-9. PubMed ID: 2136432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum hexosamine and its correlations with serum iron, copper, and iron-binding capacity in bronchogenic pulmonary carcinoma.
    Kokkola K; Tani P
    Scand J Respir Dis Suppl; 1972; 80():137-41. PubMed ID: 4510910
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood coagulation and fibrinolysis in patients with carcinoma of the lung.
    Brugarolas A; Elias EG; Takita H; Mink IB; Mittelman A; Ambrus JL
    J Med; 1973; 4(2):96-105. PubMed ID: 4127138
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum iron, copper, and iron-binding capacity in bronchogenic pulmonary carcinoma.
    Tani P; Kokkola K
    Scand J Respir Dis Suppl; 1972; 80():121-8. PubMed ID: 4510909
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypercalcemia in bronchogenic carcinoma.
    Shankar PS
    J Assoc Physicians India; 1979 Jan; 27(1):19-25. PubMed ID: 511820
    [No Abstract]   [Full Text] [Related]  

  • 9. Bronchogenic carcinoma and hypercalcemia.
    Lueg MC; Barkman HW
    J La State Med Soc; 1985 May; 137(5):66-70. PubMed ID: 4020358
    [No Abstract]   [Full Text] [Related]  

  • 10. [Blood chemical parameters in the monitoring of inoperable bronchogenic carcinoma].
    Barberis S; Ciotta D; Fusaro E; Galietti F; Giorgis GE; Oliaro A; Scappaticci E
    Minerva Med; 1986 Oct; 77(39):1789-92. PubMed ID: 3774198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of the determination of alpha-1-antitrypsin and pregnancy-associated alpha-1-glycoprotein in the serum of patients with bronchogenic carcinoma].
    Homolka J; Voslárová Z; Malbohan I
    Cas Lek Cesk; 1987 Jan; 126(3):73-5. PubMed ID: 3492274
    [No Abstract]   [Full Text] [Related]  

  • 12. [Alpha-subunit of human chorionic gonadotropin in bronchogenic carcinoma].
    Zatloukal P; Glagolicová A; Mĕricka O; Bezdícek P
    Sb Lek; 1993; 94(4):327-31. PubMed ID: 7527586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Some biochemical possibilities for early bronchogenic carcinoma diagnosis].
    Procházka J; Kopecký P; Deyl Z; Svojtková E; Smíd A; Burian I
    Cas Lek Cesk; 1976 Oct; 115(41):1262-5. PubMed ID: 991175
    [No Abstract]   [Full Text] [Related]  

  • 14. [Significance of the relative seimentation rate in the diagnosis of bronchial carcnoma].
    Eiter E
    Wien Med Wochenschr; 1967 Mar; 117(11):268-70. PubMed ID: 5585998
    [No Abstract]   [Full Text] [Related]  

  • 15. [Screening and transcortin binding capacity of ectopic ACTH producing lung cancer].
    Kusama M; Abe O; Sakauchi N; Kumaoka S; Ishikawa S
    Gan No Rinsho; 1969 Oct; 15(10):859-65. PubMed ID: 4310775
    [No Abstract]   [Full Text] [Related]  

  • 16. Atypical plasma factor associated with bronchogenic carcinoma and complexing with R-type vitamin B12-binding proteins.
    Jacob E; Herbert V; Burger RL; Allen RH
    N Engl J Med; 1977 Apr; 296(16):915-7. PubMed ID: 846512
    [No Abstract]   [Full Text] [Related]  

  • 17. [Blood cortisol in neoplasm cases].
    Lewis W; Nadeau P; Fauteux J; Ostiguy G; Leblanc P; Chrétien M
    Union Med Can; 1971 Aug; 100(8):1563-8. PubMed ID: 4327162
    [No Abstract]   [Full Text] [Related]  

  • 18. Adenosine deaminase and purine nucleoside phosphorylase activities in peripheral blood cells of patients with neoplastic diseases. I. Bronchogenic carcinoma.
    Rendeková V; Cerná M; Cerná M; Pechánová E; Pechán I; Krizko J; Virsík K
    Neoplasma; 1983; 30(2):233-8. PubMed ID: 6405288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte rubidium uptake in normal and cancer patients.
    Vogel JM; Scott KG
    Arch Intern Med; 1968 Jan; 121(1):76-80. PubMed ID: 5635075
    [No Abstract]   [Full Text] [Related]  

  • 20. [Blood protein electrophoresis in bronchogenic carcinoma and tuberculosis].
    Romeiro-Neto M; Barroso FC; Takagaki TY; Carvalho CR; Barbas Filho JV; Adriollo A
    Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(3):75-7. PubMed ID: 3454051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.